Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice
- 1 November 2010
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 80 (10) , 1601-1612
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Polyenephosphatidylcholine prevents alcoholic liver disease in PPARα-null mice through attenuation of increases in oxidative stressJournal of Hepatology, 2009
- Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor α-Independent MechanismMolecular Pharmacology, 2009
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology, 2008
- Non-alcoholic fatty liver disease: The mist gradually clearsJournal of Hepatology, 2008
- Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator‐activated receptor α in transgenic mice: Implications for HCV‐associated hepatocarcinogenesisInternational Journal of Cancer, 2007
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by Srebp–1 SuppressionHepatology, 2003
- In vivo stabilization of nuclear retinoid X receptor α in the presence of peroxisome proliferator‐activated receptor αFEBS Letters, 2003
- A Novel Disease with Deficiency of Mitochondrial Very-Long-Chain Acyl-CoA DehydrogenaseBiochemical and Biophysical Research Communications, 1993
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985